Targeting the Transforming Growth Factor-β Signaling in Cancer Therapy
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting the Transforming Growth Factor-β Signaling in Cancer Therapy
Authors
Keywords
-
Journal
Biomolecules & Therapeutics
Volume 21, Issue 5, Pages 323-331
Publisher
The Korean Society of Applied Pharmacology
Online
2013-11-01
DOI
10.4062/biomolther.2013.072
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A phase I study of tasisulam sodium (LY573636 sodium), a novel anticancer compound, administered as a 24-h continuous infusion in patients with advanced solid tumors
- (2012) Michael S. Gordon et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Complexities of TGF-β Targeted Cancer Therapy
- (2012) Erin C. Connolly et al. International Journal of Biological Sciences
- Anti-human Activin Receptor-like Kinase 1 (ALK1) Antibody Attenuates Bone Morphogenetic Protein 9 (BMP9)-induced ALK1 Signaling and Interferes with Endothelial Cell Sprouting
- (2012) Laurens A. van Meeteren et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Healthy Lifestyle on the Risk of Breast Cancer
- (2011) L. M. Sanchez-Zamorano et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- TGF-beta signalling in colon carcinogenesis
- (2011) Pavlos Lampropoulos et al. CANCER LETTERS
- Outgrowth of Drug-Resistant Carcinomas Expressing Markers of Tumor Aggression after Long-term T RI/II Kinase Inhibition with LY2109761
- (2011) E. C. Connolly et al. CANCER RESEARCH
- EW-7203, a novel small molecule inhibitor of transforming growth factor-β (TGF-β) type I receptor/activin receptor-like kinase-5, blocks TGF-β1-mediated epithelial-to-mesenchymal transition in mammary epithelial cells
- (2011) Chul-Yong Park et al. CANCER SCIENCE
- Transforming growth factor-beta 2 gene silencing with trabedersen (AP 12009) in pancreatic cancer
- (2011) Karl-Hermann Schlingensiepen et al. CANCER SCIENCE
- TGF-β regulates isoform switching of FGF receptors and epithelial-mesenchymal transition
- (2011) Takuya Shirakihara et al. EMBO JOURNAL
- EW-7195, a novel inhibitor of ALK5 kinase inhibits EMT and breast cancer metastasis to lung
- (2011) Chul-Yong Park et al. EUROPEAN JOURNAL OF CANCER
- Molecular characterization of TGFβ-induced epithelial-mesenchymal transition in normal finite lifespan human mammary epithelial cells
- (2010) Linsey E. Lindley et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The TGF-β/Smad pathway induces breast cancer cell invasion through the up-regulation of matrix metalloproteinase 2 and 9 in a spheroid invasion model system
- (2010) Eliza Wiercinska et al. BREAST CANCER RESEARCH AND TREATMENT
- Inhibitory effect of a TGFβ receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells
- (2010) O Shinto et al. BRITISH JOURNAL OF CANCER
- Homeoprotein Six1 Increases TGF- Type I Receptor and Converts TGF- Signaling from Suppressive to Supportive for Tumor Growth
- (2010) D. S. Micalizzi et al. CANCER RESEARCH
- TGF- -RI Kinase Inhibitor SD-208 Reduces the Development and Progression of Melanoma Bone Metastases
- (2010) K. S. Mohammad et al. CANCER RESEARCH
- Gene–environment interactions in 7610 women with breast cancer: prospective evidence from the Million Women Study
- (2010) Ruth C Travis et al. LANCET
- Targeting the Transforming Growth Factor-β pathway inhibits human basal-like breast cancer metastasis
- (2010) Vidya Ganapathy et al. Molecular Cancer
- Transforming growth factor-β-induced epithelial–mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression
- (2010) M K Wendt et al. ONCOGENE
- TGF-β Inhibition Restores Terminal Osteoblast Differentiation to Suppress Myeloma Growth
- (2010) Kyoko Takeuchi et al. PLoS One
- Targeting transforming growth factor-β signaling in liver metastasis of colon cancer
- (2009) Bixiang Zhang et al. CANCER LETTERS
- Epithelial-Mesenchymal Transitions in Development and Disease
- (2009) Jean Paul Thiery et al. CELL
- The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-β signaling
- (2009) Douglas S. Micalizzi et al. JOURNAL OF CLINICAL INVESTIGATION
- Imaging transforming growth factor-β signaling dynamics and therapeutic response in breast cancer bone metastasis
- (2009) Manav Korpal et al. NATURE MEDICINE
- A role for the TGF -Par6 polarity pathway in breast cancer progression
- (2009) A. M. Viloria-Petit et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An Anti-Transforming Growth Factor Antibody Suppresses Metastasis via Cooperative Effects on Multiple Cell Compartments
- (2008) J.-S. Nam et al. CANCER RESEARCH
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
- TGFβ Primes Breast Tumors for Lung Metastasis Seeding through Angiopoietin-like 4
- (2008) David Padua et al. CELL
- TGFβ in Cancer
- (2008) Joan Massagué CELL
- Roles of TGFβ in metastasis
- (2008) David Padua et al. CELL RESEARCH
- LY2109761, a novel transforming growth factor receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis
- (2008) D. Melisi et al. MOLECULAR CANCER THERAPEUTICS
- Semi-mechanistic modelling of the tumour growth inhibitory effects of LY2157299, a new type I receptor TGF-β kinase antagonist, in mice
- (2007) Lorea Bueno et al. EUROPEAN JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now